Project Grant R01DK140948
- This federal Project Grant award of $842,633.00, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on developing an optimal prehabilitation program for kidney transplant candidates on hemodialysis. The grant aims to elicit expert opinion to identify kidney transplant-specific prehabilitation components and strategies to enhance enrollment and adherence...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Emory University a $818,481 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a longitudinal study on the quality of everyday life experiences among home dialysis patients and their family caregivers. The 5-year study, which began in September 2025, aims to characterize the quality of life and understand how home dialysis patients and their...
- This federal Project Grant award, in the amount of $531,999.00, was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award is supporting research focused on understanding the role of alternative splicing in the proximal tubules of the kidney and its relationship to the progression of diabetic kidney disease. The research will investigate how diabetes...
- The federal Project Grant award of $237,750 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is supporting a research study to examine nephrology practices' participation decisions and care model reforms under Medicare's Kidney Care Choices payment models. The study, conducted by the Trustees of Indiana University (UEI: SHHBRBAPSM35), aims to better understand how smaller...
- This $128,286 Project Grant award, provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), will support research into the mechanisms of renal lipotoxicity and its contribution to the development of chronic kidney disease (CKD). The principal investigator will investigate the protective role of the FAF2 gene knockout in mitigating palmitate-induced lipotoxicity in...
- This federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $306,867 award to Dupage Medical Technology Inc. supports the development of a new drug to treat ischemia-reperfusion injury associated with kidney transplantation. The project aims to develop a therapy that can reduce inflammation and thrombosis without causing excessive...
- This $268,500 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) will support the "Incident Hemodialysis Electrolyte Analysis and Rhythm Trends (IHEART)" study conducted by Dr. Katherine Ravi at Brigham & Women's Hospital. The study aims to investigate how cardiac rhythm morphology associated with sudden cardiac death evolves during the early stages of...
- This Project Grant award of $314,279 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) supports the development and evaluation of an innovative dialysis cannulation needle. The proposed product aims to reduce accidental needle infiltration injuries and improve the safety and efficacy of home and in-center renal dialysis therapy. The award was made to Minnesota Healthsolutions Corporation, a...
- This $196,418 federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847), supports research aimed at utilizing biosignals and biomarkers to improve the safety and efficacy of albumin infusion in patients with cirrhosis and acute kidney injury (AKI). The key goals of the project are to: 1) predict the benefits and harms of albumin infusion for AKI using clinical data, 2) define a pulse oximeter waveform 'biosignature' associated...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $350,000 Project Grant to Katharos, Inc. on Jun 20, 2025. The grant supports the development of a novel extracorporeal technology, the "Phosfilter" device, which aims to enhance phosphate removal from the blood of hemodialysis patients and reduce the incidence of high phosphate-associated morbidity and...
This federal Project Grant award of $737,949 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to modernize clinical methods for assessing fluid excess and removal during in-center hemodialysis treatment. The long-term goal is to improve patient-centered outcomes by leveraging newer techniques like multi-frequency bioelectrical impedance spectroscopy (BIS) to better quantify excess extracellular fluid and guide ultrafiltration. The award, with a performance period from Sep 24, 2025 to Jun 30, 2030, will gather evidence on the potential utility of BIS to enhance the patient experience immediately following and during the post-dialysis period.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $737.9k | 9/24/25 |